---
title: "Sanyou Bio"
description: "A high-tech biopharmaceutical company with a business model driven by AI technology, supported by intelligent R&D platforms and guided by its innovative drug pipeline."
canonical: "https://presspool.ai/companies/sanyoubio-com"
last-updated: "2026-11-14"
---

# Sanyou Bio

A high-tech biopharmaceutical company with a business model driven by AI technology, supported by intelligent R&D platforms and guided by its innovative drug pipeline. [sanyoubio.com](https://sanyoubio.com)

Company record · Updated November 14, 2026 · Presspool · https://presspool.ai/companies/sanyoubio-com

## Funding

Latest announced financing: nearly RMB 100 million, Series C, announced November 9, 2026.

- **nearly RMB 100 million Series C**, announced November 9, 2026. Sole investor named: Zero2IPO Industry Investment. The company says the round funds its AI-driven drug R&D system, whose core engine is the Sanyou AI-Drug Accelerator (SAI-DA). Listed in the [AI startup funding roster for November 8–14, 2026](https://presspool.ai/ai-startup-funding/week-of-2026-11-09). Sources: [PR Newswire (company release)](https://www.prnewswire.com/news-releases/sanyou-bio-secures-exclusive-series-c-investment-from-zero2ipo-industry-investment-bringing-total-funding-to-nearly-rmb-300-million-302932833.html), [Fineline Cube (flcube.com)](https://flcube.com/sanyou-biopharmaceuticals-completes-series-c-financing-of-nearly-rmb-100-million-zero2ipo-industry-investment-fund-backs-ai-driven-drug-discovery-platform).

## Whether AI names Sanyou Bio

- Machine Relations Index: Not cited in any Machine Relations Index answer, May 10, 2026 to November 14, 2026.

A company counts when an AI answer names it or cites its website. Answers vary from run to run, so each count is a dated sample.

## Related records

- Closest rounds in the [roster for November 8–14, 2026](https://presspool.ai/ai-startup-funding/week-of-2026-11-09): [LangChain](https://presspool.ai/companies/langchain-com) ($300 million Series C, November 13, 2026), [Q-CTRL](https://presspool.ai/companies/q-ctrl-com) (US$290 million Series C, November 12, 2026), [Fractile](https://presspool.ai/companies/fractile-com) ($720 million Series C, November 11, 2026), [Finite State](https://presspool.ai/companies/finitestate-io) ($27 million Series C, November 10, 2026), [Nominal](https://presspool.ai/companies/nominal-io) ($240 million Series C, November 9, 2026), [Morsa](https://presspool.ai/companies/morsa-ai) ($1.5 million pre-seed, November 13, 2026).

## Sources

- [PR Newswire (company release)](https://www.prnewswire.com/news-releases/sanyou-bio-secures-exclusive-series-c-investment-from-zero2ipo-industry-investment-bringing-total-funding-to-nearly-rmb-300-million-302932833.html)
- [Fineline Cube (flcube.com)](https://flcube.com/sanyou-biopharmaceuticals-completes-series-c-financing-of-nearly-rmb-100-million-zero2ipo-industry-investment-fund-backs-ai-driven-drug-discovery-platform)

---

Presspool is a sourced record of AI startup funding. Rounds are listed because they were publicly announced, and no company pays to be listed.

Published by [Jaxon Parrott](https://jaxonparrott.com). Jaxon Parrott coined [Machine Relations](https://machinerelations.ai) in 2024. [AuthorityTech](https://authoritytech.io), which he founded in 2018, is The World's First Machine Relations Agency.

A [Bramwell, Inc.](https://bramwell.ai/companies/presspool/) company

More: [Tracker](https://presspool.ai/) · [Funding](https://presspool.ai/ai-startup-funding) · [Niches](https://presspool.ai/niches) · [Founders](https://presspool.ai/founders) · [Investors](https://presspool.ai/investors) · [Method](https://presspool.ai/method) · [About](https://presspool.ai/about) · [Contact](https://presspool.ai/contact) · [API](https://presspool.ai/api) · [llms.txt](https://presspool.ai/llms.txt)